3rd Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for WYETH

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act of 2007 ***, no specific bill(s), Alzheimers Research, Hormone Replacement Therapy, Vaccine Program

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. on Finance;
ISAAC A FORDJOUR —
LINDA E TARPLIN Congressman Billy Tauzin
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg.

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office

Bills named: H.R. 1812 (110th)

Medicare/Medicaid MMM

**see addendum page Medicare Physician Reimbursement Package, Medicare and Medicaide Drug Reimbursement, Medicaid Rebate H.R. 6331/S. 3101 - Medicare Improvements for Patients and Providers Act of 2008 S. 3118 - Preserving Access to Medicare Act of 2008 S. 2029 - Physician Payments Sunshine Act of 2007 - disclosure H.R. 5605 - Physician Payments Sunshine Act of 2008 - disclosure ***, no specific bill(s), Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. on Finance;
ISAAC A FORDJOUR —
LINDA E TARPLIN Congressman Billy Tauzin
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg.

Contacted: Health & Human Services, Dept of (HHS); White House Office; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 3101 (110th), S. 3118 (110th), H.R. 5605 (110th), S. 2029 (110th), H.R. 6331 (110th)

Pharmacy PHA

**see addendum page Biosimilars H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/H.R. 1038 - Access to Life - Saving Medicine Act, Follow-On Biologics S. 1695 - Biologics Price Competition and Innovation Act of 2007 S. 1505 - Affordable Biologics for Consumers Act H.R. 5629 - Pathway for Biosimilars Act Import Safety H.R. 3610 - Food and Drug Import Safety Act of 2007 S. 3409 Drug and Device Accountability Act of 2008 ***, no specific bill(s), Biosimilars, Drug Safety, Prescription Drug Importation, Import Safety, Compounding

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. on Finance;
ISAAC A FORDJOUR —
LINDA E TARPLIN Congressman Billy Tauzin
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg.

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; Food & Drug Administration (FDA)

Bills named: S. 623 (110th), H.R. 3610 (110th), H.R. 1038 (110th), S. 3409 (110th), S. 1505 (110th), H.R. 1956 (110th), H.R. 5629 (110th), S. 1695 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.